Latent Tuberculosis Infection Screening in Immigrants to Low-Incidence Countries: A Meta-Analysis
Immigration from regions with a high incidence of tuberculosis (TB) has slowed the decline of TB in low-incidence regions. Targeted screening of new immigrants and treatment for latent TB infection (LTBI) is needed to reinvigorate this decline. This meta-analysis compares LTBI diagnostic tests by positive test prevalence and proportion of positive tests by TB incidence.
A systematic literature search was performed and data extracted based on tuberculin skin test (TST) and/or interferon-gamma release assay (IGRA) use in immigrants. For the eight studies performing tests concurrently, data were compared by positive tests and concordance, while other studies comparing individual tests were analyzed based on demographic factors. Data were analyzed via meta-analysis.
Forty-five studies with a combined sample size of 93,249 individuals were included in the analyses, 2206 of which were from the eight concurrent studies. Odds of a positive TST were significantly higher than an IGRA (odds ratio 1.46; 95 % confidence interval 1.07–2.01) and test agreement was moderate. Proportion of positive TST and IGRA tests increased with TB incidence, although not linearly.
TST and IGRA data relating to immigrants are lacking, especially long-term follow-up and comparative data. Further data are urgently needed to determine TB risks after immigration, long-term TB development, and treatment outcomes.
KeywordsTuberculin Skin Test Positive Tuberculin Skin Test LTBI Treatment LTBI Screening IGRA Test
Funding and conflict of interest
The authors have no funding sources or conflicts of interest to declare at this time.
Jonathon R. Campbell: Literature search, statistical analysis, draft writing. Wenjia Chen: Statistical analysis and methodology. James Johnston, Victoria Cook, Kevin Elwood: Expert opinion, manuscript review. Jane Krot: Literature search. Fawziah Marra: Conception, statistical interpretation, implications, manuscript editing and review.
- 2.Gilbert RL, Antoine D, French CE, Abubakar I, Watson JM, Jones JA. The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2009;13:645–51.Google Scholar
- 4.Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Manchester (UK): National Institute for Health and Clinical Excellence; 2011. Available: http://www.nice.org.uk/guidance/cg117. Accessed 7 Jan 2015.
- 5.Canadian Tuberculosis Standards. 7th ed. Ottawa (ON): Canadian Thoracic Society; 2013. Available: http://www.respiratoryguidelines.ca/tb-standards-2013. Accessed 7 Jan 2015.
- 7.Alvarez GG, Gushulak B, Abu Rumman K, Altpeter E, Chemtob D, Douglas P, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis. 2011;11:3.CrossRefPubMedCentralPubMedGoogle Scholar
- 9.Latent tuberculosis infection: a guide for primary health care providers. Atlanta (GA): Centers for Disease Control and Prevention; 2013. Available: http://www.cdc.gov/tb/publications/ltbi/diagnosis.htm. Accessed 7 Jan 2015.
- 11.Mazurek GH, Villarino ME, CDC. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 2003;52:15–8.Google Scholar
- 13.Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(264–9):W64.Google Scholar
- 14.Critical Appraisal. Methodology checklist 5: diagnostic studies. Scotland: SIGN; 2013. Available: http://www.sign.ac.uk/methodology/checklists.html. Accessed 7 Jan 2015.
- 16.Framework towards TB Elimination in low-incidence countries. Switzerland: World Health Organization; 2014. Available: http://apps.who.int/iris/bitstream/10665/132231/1/9789241507707_eng.pdf?ua=1. Accessed 7 Jan 2015.
- 23.Losi M, Bergamini BM, Venturelli C, Del Giovane C, Sighinolfi G, Rumpaneisi F, et al. Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2011;15:1182–4, i.Google Scholar
- 25.Saracino A, Scotto G, Fornabaio C, Martinelli D, Faleo G, Cibelli D, et al. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy. N Microbiol. 2009;32:369–76.Google Scholar
- 27.Painter JA, Graviss EA, Hai HH, Nhung DTC, Nga TTT, Ha NP, et al. Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination. PloS One. 2013;8:e82727.CrossRefPubMedCentralPubMedGoogle Scholar
- 29.Harstad I, Winje BA, Heldal E, Oftung F, Jacobsen GW. Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2010;14:1209–11.Google Scholar
- 31.Levesque JF, Dongier P, Brassard P, Allard R. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2004;8:711–7.Google Scholar
- 39.MacIntyre CR, Plant AJ. Longitudinal incidence of tuberculosis in South–East Asian refugees after re-settlement. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 1999;3:287–93.Google Scholar
- 41.Hobbs M, Moor C, Wansbrough T, Calder L. The health status of asylum seekers screened by Auckland Public Health in 1999 and 2000. NZ Med J. 2002;115:U152.Google Scholar
- 48.Fernández Sanfrancisco MT, Díaz Portillo J, Sánchez Romero JM, Pérez Fernández A, Vadillo Andrade J. Prevalence of tuberculosis among the immigrant population in Ceuta. Spain. Rev Esp Salud Pública. 2001;75:551–8.Google Scholar
- 49.Lifson AR, Thai D, O’Fallon A, Mills WA, Hang K. Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota. Public Health Rep Wash DC. 1974;2002(117):69–77.Google Scholar
- 67.Machado A, Emodi K, Takenami I, Finkmoore BC, Barbosa T, Carvalho J, et al. Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2009;13:446–53.Google Scholar
- 69.Chiappini E, Bonsignori F, Mazzantini R, Sollai S, Venturini E, Mangone G, et al. Interferon-gamma release assay sensitivity in children younger than 5 years is insufficient to replace the use of tuberculin skin test in western countries. Pediatr Infect Dis J. 2014;33:1291–3.CrossRefPubMedGoogle Scholar
- 70.Wlodarczyk M, Rudnicka W, Janiszewska-Drobinska B, Kielnierowski G, Kowalewicz-Kulbat M, Fol M, et al. Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis. PLoS One. 2014;9:e107208.CrossRefPubMedCentralPubMedGoogle Scholar